| Dr Nidhi Mehta, MD | |
|
2649 Schoenersville Rd, Suite 301, Bethlehem, PA 18017-7326 | |
| (484) 884-4799 | |
| (484) 884-4730 |
| Full Name | Dr Nidhi Mehta |
|---|---|
| Gender | Female |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 16 Years |
| Location | 2649 Schoenersville Rd, Bethlehem, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144482720 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | MD440799 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lehigh Valley Hospital | Allentown, PA | Hospital |
| St Luke's Hospital Bethlehem | Bethlehem, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lehigh Valley Physician Group | 3072425123 | 1763 |
News Archive
Allergan, Inc. today announced that the United States Food and Drug Administration (FDA) has approved OZURDEX (dexamethasone intravitreal implant) 0.7 mg for the treatment of non-infectious ocular inflammation, or uveitis, affecting the posterior segment of the eye.
Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care, today announced the U.S. Food and Drug Administration (FDA) has agreed to the Company's updated product specifications for SURFAXIN® (lucinactant) Intratracheal Suspension which was approved for the prevention of respiratory distress syndrome (RDS) in premature infants at high risk for RDS.
A relatively newly discovered group of immune cells known as ILCs have been examined in detail in a new study published in the journal Nature Immunology. By analysing the gene expression in individual tonsil cells, scientists at Karolinska Institutet in Sweden have found three previously unknown subgroups of ILCs, and revealed more about how these cells function in the human body.
In a world first, new Australian medical research has given pregnant women with epilepsy new hope of reducing their chance of having a baby with physical birth defects.
› Verified 1 days ago
| Entity Name | Lehigh Valley Physician Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457309650 PECOS PAC ID: 3072425123 Enrollment ID: O20040227000335 |
News Archive
Allergan, Inc. today announced that the United States Food and Drug Administration (FDA) has approved OZURDEX (dexamethasone intravitreal implant) 0.7 mg for the treatment of non-infectious ocular inflammation, or uveitis, affecting the posterior segment of the eye.
Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care, today announced the U.S. Food and Drug Administration (FDA) has agreed to the Company's updated product specifications for SURFAXIN® (lucinactant) Intratracheal Suspension which was approved for the prevention of respiratory distress syndrome (RDS) in premature infants at high risk for RDS.
A relatively newly discovered group of immune cells known as ILCs have been examined in detail in a new study published in the journal Nature Immunology. By analysing the gene expression in individual tonsil cells, scientists at Karolinska Institutet in Sweden have found three previously unknown subgroups of ILCs, and revealed more about how these cells function in the human body.
In a world first, new Australian medical research has given pregnant women with epilepsy new hope of reducing their chance of having a baby with physical birth defects.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nidhi Mehta, MD Po Box 783311, Philadelphia, PA 19178-3311 Ph: () - | Dr Nidhi Mehta, MD 2649 Schoenersville Rd, Suite 301, Bethlehem, PA 18017-7326 Ph: (484) 884-4799 |
News Archive
Allergan, Inc. today announced that the United States Food and Drug Administration (FDA) has approved OZURDEX (dexamethasone intravitreal implant) 0.7 mg for the treatment of non-infectious ocular inflammation, or uveitis, affecting the posterior segment of the eye.
Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care, today announced the U.S. Food and Drug Administration (FDA) has agreed to the Company's updated product specifications for SURFAXIN® (lucinactant) Intratracheal Suspension which was approved for the prevention of respiratory distress syndrome (RDS) in premature infants at high risk for RDS.
A relatively newly discovered group of immune cells known as ILCs have been examined in detail in a new study published in the journal Nature Immunology. By analysing the gene expression in individual tonsil cells, scientists at Karolinska Institutet in Sweden have found three previously unknown subgroups of ILCs, and revealed more about how these cells function in the human body.
In a world first, new Australian medical research has given pregnant women with epilepsy new hope of reducing their chance of having a baby with physical birth defects.
› Verified 1 days ago
Ashokkumar H Gaba, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2649 Schoenersville Rd, Bethlehem, PA 18017 Phone: 484-884-9677 | |
Kathryn Mae Pisarcik, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2545 Schoenersville Rd Fl 2, Bethlehem, PA 18017 Phone: 484-884-9677 Fax: 484-884-9297 | |
Dr. Minh Quang Nguyen, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2300 Highland Ave, Bethlehem, PA 18020 Phone: 610-402-3110 | |
Dr. Jonathan H Munves, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2597 Schoenersville Rd, Suite 302, Bethlehem, PA 18017 Phone: 610-691-6222 Fax: 484-403-4011 | |
Dr. Anna Alina Niewiarowska, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 306 S New St Ste 201, Bethlehem, PA 18015 Phone: 610-866-0113 Fax: 610-974-8589 | |
Gonzalo Pimentel, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 2545 Schoenersville Rd, Bethlehem, PA 18017 Phone: 484-884-9677 | |
Jeffrey Faidley, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2545 Schoenersville Rd, Bethlehem, PA 18017 Phone: 484-884-9677 |